(Q50760539)

18 March 2018

title

Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer. (English)

1 reference

18 March 2018

1 reference

2

Caroline Seynaeve

1 reference

18 March 2018

Paul A M Meeuwissen

1

1 reference

18 March 2018

Cecile T M Brekelmans

3

1 reference

18 March 2018

Hanne J Meijers-Heijboer

4

1 reference

18 March 2018

Jan G M Klijn

5

1 reference

18 March 2018

Curt W Burger

6

1 reference

18 March 2018

language of work or name

English

0 references

publication date

1 May 2005

1 reference

18 March 2018

published in

Gynecologic Oncology

1 reference

18 March 2018

volume

97

1 reference

18 March 2018

issue

2

1 reference

18 March 2018

page(s)

476-482

1 reference

18 March 2018

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Cancer risks in BRCA2 mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

The performance of screening tests for ovarian cancer: results of a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Prospectively detected cancer in familial breast/ovarian cancer screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Screening for ovarian cancer: a pilot randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Long-term follow-up of the Stockholm screening study on ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

CA 125: fundamental and clinical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

The effect of the menstrual cycle on serum CA 125 levels: a population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Differential diagnosis of ovarian cancer with tumour markers CA 125, CA 15-3 and TAG 72.3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Current status of prophylactic surgery for hereditary breast and gynecologic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

A morphology index based on sonographic findings in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Feasibility study of a randomised trial of ovarian cancer screening among the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Three-dimensional ultrasound and power doppler improve the diagnosis of ovarian lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Familial ovarian cancer. A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Occult cancer in the fallopian tube in patients with a BRCA-1 germline mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Prophylactic surgery in patients with inherited risk of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Fallopian tube cancer in a BRCA1 mutation carrier: Rapid development and failure of screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Risks of cancer among members of families in the Gilda Radner Familial Ovarian Cancer Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Risk of Endometrial Carcinoma Associated with BRCA Mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

BRCA1 germline mutations in women with uterine serous papillary carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

Cancer Incidence in BRCA1 mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.024

10.1016/J.YGYNO.2005.01.024

7 January 2021

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018